<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412018000900567</article-id>
<article-id pub-id-type="doi">10.24245/gom.v86i9.1229</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Correlación entre ácido úrico y creatinina sérica en pacientes embarazadas con preeclampsia severa]]></article-title>
<article-title xml:lang="en"><![CDATA[Correlation of uric acid and serum creatinine in pregnant patients with severe preeclampsia.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[Juan Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Isla-Arias]]></surname>
<given-names><![CDATA[Myrna Xazny]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,IMSS Unidad de Cuidados Intensivos Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<volume>86</volume>
<numero>9</numero>
<fpage>567</fpage>
<lpage>574</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412018000900567&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412018000900567&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412018000900567&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO: Determinar la correlación entre las concentraciones de ácido úrico y creatinina en pacientes con preeclampsia severa para conocer su utilidad clínica.  MATERIALES Y MÉTODOS: Estudio retrospectivo, transversal y analítico al que se incluyeron pacientes con preeclampsia severa. A la admisión al estudio se registraron las concentraciones sanguíneas de ácido úrico y creatinina para calcular la correlación de las medias generales y por categorías. Se utilizó estadística descriptiva, prueba t de Student, IC95% y coeficiente de correlación de Pearson con el programa estadístico SPSS versión 20.  RESULTADOS: Se estudiaron 100 pacientes con preeclampsia severa. La media ge-neral de ácido úrico fue de 5.52 ± 1.43 mg/dL; 85% tuvieron hiperuricemia y 17% hiperuricemia extrema. La media general de creatinina fue de 0.77 ± 0.25 mg/dL; 18% resultaron con hiperazoemia y 14% con hiperazoemia extrema.  CONCLUSIONES: El ácido úrico y la creatinina tuvieron correlaciones positivas: a mayor hiperuricemia mayor deterioro de la función renal. Ambos pueden ser marcadores complementarios útiles para identificar la lesión renal aguda en la preeclampsia severa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE: To determine the correlation of uric acid and creatinine in pregnant patients with severe preeclampsia to identify its clinical utility.  MATERIAL AND METHOD: cross- sectional study that included 100 pregnant patients with severe preeclampsia. Blood levels of uric acid and creatinine were recorded upon admission to calculate the correlation of the general means and by categories. (Normal uric acid &#8804; 4 mg/dL, hyperuricemia &gt; 4 mg/dL and extreme hyperuricemia &#8805;7 mg/dL vs normal creatinine &#8804; 0.9 mg/dL, hyperazotemia &gt; 0.9 mg/dL and extreme hiperazoemia &#8805; 1.1 mg/dL). Descriptive statistics, Student's T- test, Confidence inter-vals (CI) and Pearson's correlation coefficient were used with the statistical program SPSS version 20.  RESULTS: 100 patients with severe preeclampsia were studied. The general average of uric acid was 5.52 ± 1.43 mg / dL; 85% had hyperuricemia and 17% extreme hy-peruricemia. The general average of creatinine was 0.77 ± 0.25 mg / dL; 18% resulted with hyperazotemia and 14% with extreme azotemia.  CONCLUSIONS: Uric acid and creatinine showed positive correlations. It was found that the greater the degree of hyperuricemia, the greater the deterioration of renal function. Both markers can be complemented to identify acute kidney injury in severe preeclampsia.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Ácido úrico]]></kwd>
<kwd lng="es"><![CDATA[creatinina sérica]]></kwd>
<kwd lng="es"><![CDATA[lesión renal aguda]]></kwd>
<kwd lng="es"><![CDATA[preeclampsia severa]]></kwd>
<kwd lng="es"><![CDATA[cuidados intensivos obstétricos]]></kwd>
<kwd lng="es"><![CDATA[embarazo de alto riesgo.]]></kwd>
<kwd lng="en"><![CDATA[Uric acid]]></kwd>
<kwd lng="en"><![CDATA[Serum creatinine]]></kwd>
<kwd lng="en"><![CDATA[Acute renal injury]]></kwd>
<kwd lng="en"><![CDATA[Severe preeclampsia]]></kwd>
<kwd lng="en"><![CDATA[Obstetric intensive care]]></kwd>
<kwd lng="en"><![CDATA[High-risk pregnancy.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>WHO</collab>
<source><![CDATA[recommendations for prevention and treatment of pre-eclampsia and eclampsia]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lo]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertensive disease of pregnancy and ma-ternal mortality]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pridjian]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Puschett]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preeclampsia. Part 1: Clinical and pathophysiologic considerations]]></article-title>
<source><![CDATA[Obstet Gynecol Survey]]></source>
<year>2000</year>
<volume>57</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>598-618</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>American College of Obstetricians and Gynecologists (ACOG)</collab>
<source><![CDATA[Task Force on Hypertension in Pregnanc]]></source>
<year>2013</year>
<page-range>1-89</page-range><publisher-loc><![CDATA[Washington, DC ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Guía de Práctica Clínica</collab>
<source><![CDATA[Prevención, Diagnóstico y Tratamiento de la preeclampsia en el se-gundo y tercer nivel de atención]]></source>
<year>2017</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stamilio]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2000</year>
<volume>182</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>589-94</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Powers RW]]></surname>
<given-names><![CDATA[et.al.]]></given-names>
</name>
</person-group>
<source><![CDATA[Uric acid concentrations in early preg-nancy among preeclamptic women with gestational hyperuricemia at delivery]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<source><![CDATA[Lehninger. Principios de Bioquímica]]></source>
<year>2001</year>
<edition>3ª</edition>
<page-range>860-7</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Omega]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bainbridge]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Uric acid as a pathogenic factor in preeclampsia.]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mustafa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[A comprehensive review of hypertension in pregnancy]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Rico-Trejo]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complicaciones maternas en pacientes con preeclampsia e hiperuricemia tratadas en la unidad de cuidados intensivos]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2016</year>
<volume>84</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>143-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Rico-Trejo]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Papel del ácido úrico en la preeclampsia-eclampsia]]></article-title>
<source><![CDATA[Ginecol Obstet Mex.]]></source>
<year>2011</year>
<volume>79</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>292-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>IMSS</collab>
<source><![CDATA[Guías de práctica clínica. Detección y diagnostico de enfermedades hipertensivas del Embarazo]]></source>
<year>2015</year>
<publisher-name><![CDATA[Instituto Mexicano del Seguro Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chamy]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<source><![CDATA[Perfil clínico de embarazadas con pree-clampsia y embarazos no complicados]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voet]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Voet]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[ChW]]></surname>
<given-names><![CDATA[Pratt]]></given-names>
</name>
</person-group>
<source><![CDATA[Fundamentos deBioquímica]]></source>
<year>2007</year>
<edition>2a</edition>
<page-range>809-14</page-range><publisher-loc><![CDATA[Médica Panamericana ]]></publisher-loc>
<publisher-name><![CDATA[Buenos Aires]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<source><![CDATA[Acute Kidney Injury Networt: report of an initiative to improve outcomes in acute kidney injury]]></source>
<year>2007</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<collab>The Society of Obstetricians and Gynecologists of Canada</collab>
<source><![CDATA[Clinical Practice Guideline. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary]]></source>
<year>2014</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
